|1.||Hata, Mitsumasa: 3 articles (06/2011 - 08/2008)|
|2.||Minami, Kazutomo: 3 articles (06/2011 - 08/2008)|
|3.||Sezai, Akira: 3 articles (06/2011 - 08/2008)|
|4.||Yoshitake, Isamu: 2 articles (06/2011 - 01/2009)|
|5.||Suzuki, Mitsunori: 2 articles (01/2009 - 08/2008)|
|6.||Niino, Tetsuya: 2 articles (01/2009 - 08/2008)|
|7.||Unosawa, Satoshi: 2 articles (01/2009 - 08/2008)|
|8.||Nerdal, A: 1 article (12/2015)|
|9.||Watfeh, R: 1 article (12/2015)|
|10.||Baron, R: 1 article (12/2015)|
09/01/2010 - "We completed a comprehensive search of the English language literature, most recently in October 2009, and identified a total of 62 studies publishing disaggregated hearing outcome data of patients undergoing microsurgical resection of VS. Inclusion criteria for articles were: (i) hearing preservation rates were reported specifically for VS; (ii) hearing status was reported using the American Association of Otolaryngology-Head and Neck Surgery (AAO-HNS) or Gardner-Robertson (GR) classification; and (iii) initial tumor size was documented. "
09/01/2014 - "Rates of optimal tumor debulking were almost similar between groups (92.6 vs. 91.7 %, type I vs. II, P = NS). "
07/01/2014 - "Overall, we did not observe a direct association between the ACE I/D polymorphism and general cancer risk (DD + DI vs. II OR = 0.95, 95 %CI = 0.84-1.07, P = 0.40). "
07/01/2014 - "Effects may also vary by clinical characteristics (e.g., differences for Type I vs. II tumors). "
12/01/2013 - "Our meta-analysis identified that elevated cancer risk was statistically associated with -196 to -174 del allele in -196 to -174 del polymorphism (OR=1.63, 95% CI=1.10-2.41 for allele comparison; OR=1.64, 95% CI=1.05-2.57 for dominant model; OR=2.26, 95% CI=1.24-4.12 for recessive model; OR=2.57, 95% CI=1.30-5.08 for DD vs. II and OR=1.53, 95% CI=1.01-2.32 for ID vs. II in codominant model); whereas rs3804099 in TLR-2 was associated with decreased cancer risk. "
|2.||Neoplasm Metastasis (Metastasis)
09/01/2004 - "Multivariate analyses identified an earlier primary tumor stage (I vs II) (P<.001), an absence of intervening stage III metastases (P =.02), solitary metastasis (P<.001), and a long (>36 months) disease-free interval from AJCC stage I or II to stage IV (P =.005) as predictive of survival. "
03/01/2014 - "In univariate analysis, stage (I vs II, III, IV), depth of tumor invasion (T1 vs T2, T3, T4), presence of lymph node metastasis and SUVmax (>5.74 vs ≤5.74) were significantly associated with recurrence. "
11/01/2006 - "HD was confirmed in 4 out of 6 cell lines and in 8 out of 34 (23.5%) RCC specimens, which correlated with the presence of metastasis, high tumor grade and had a tendency to more advanced stage (I vs. II-IV). "
09/01/1999 - "Cyclin D1 overexpression is significantly higher in patients with lymph node metastasis (50.0% vs 14.4%, P = 0.002) and with advanced pathological stages (I, 10%; II, 53.8%; IIIa, 41.7%, P = 0.048; stage I vs II, IIIa, P = 0.006). "
01/15/1998 - "All 244 patients were subdivided into three groups described as follows: score 1 and 2, group I; score 3 and 4, group II; score 5 and 6, group III. In univariate analysis, lower score groups had better overall survival rate (OS), disease-free survival rate (DFS), local control rate (LC), and distant metastasis-free rate (DMF) than higher score groups including groups I vs. II, II vs. III, or I vs. III. The differences were all statistically significant except for the difference of the DMF in group I vs. II. In multivariate analysis, score (range 1-6) was also statistically significant in OS (p < 0.0001), DFS (p = 0.0015), LC (p = 0.0032), and DMF (p = 0.0141). "
12/01/2012 - "On univariate analysis, stage (I vs. II) (P = .006) and RT use (P = .032) were statistically significant predictors of improved overall survival in patients with indolent breast lymphoma. "
04/01/1985 - "The clinical stage (I vs. II), the site of lymphoma presentation, and the age and race of the patient did not have significant predictive value for the risk of abdominal disease after the other factors were accounted for. "
01/01/2014 - "Further analysis revealed a significant reduction of tick infestation by permethrin treatment only for subjects wearing trousers without the cut protection lining (I-2: 34.2 vs. II-2: 80.0%, p<0.001), while users of cut protection trousers did not benefit from such treated trousers (I-1: 38.6 vs. II-1: 47.6%, n.s.). "
12/01/2014 - "We sought to determine whether spinal cord stimulation (SCS) therapy, when applied chronically to canines, imparts long-lasting cardio-protective effects on neurogenic atrial tachyarrhythmia induction and, if so, whether its effects can be attributable to i) changes in intrinsic cardiac (IC) neuronal transmembrane properties vs ii) modification of their interneuronal stochastic interactivity that initiates such pathology. "
|4.||vasectrin I (VS I)
|7.||omega-N-Methylarginine (NG Monomethyl L Arginine)
|8.||Leukocyte Elastase (Neutrophil Elastase)
|9.||Messenger RNA (mRNA)
|1.||Lymph Node Excision (Lymph Node Dissection)
|5.||Renal Dialysis (Hemodialysis)